XRAY today
$9.30-$0.46 (-4.66%)close Nov 12, 2026Trend
DailyUptrend (starting)
4 hourLeaning Bearish
1 hourSymmetric Triangle
15 minSymmetric Triangle
5 minSymmetric Triangle
Daily trend turns down below $8.32
Key levels
Resistance$10.80
Resistance$9.75
Support$9.07
Support$8.13
Latest news & SEC filings
AnalystBarrington trims DENTSPLY SIRONA target to $11, keeps Outperform rating
AnalystJP Morgan lowers its valuation mark for Dentsply Sirona to $10.00
AnalystBofA Securities sets new $14 target for Dentsply Sirona
EarningsDental equipment maker posts Q3 2026 results
EarningsDentsply Sirona holds Q3 2026 earnings call
All XRAY news →About Dentsply Sirona
Dentsply Sirona develops, makes, and sells dental products and technologies, including imaging equipment, treatment centers, CAD/CAM systems, implants, clear aligners, and endodontic, restorative, and preventive consumables. It also produces continence care devices, such as catheters and irrigation systems, through its Wellspect Healthcare unit. The company sells to dental professionals, laboratories, and medical supply distributors in roughly 140 countries, with major operations in the United States and Europe.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
DENTSPLY SIRONA Inc. (XRAY)
What Is the Price Target for XRAY?
SEPT Low Target
$10.00
SEPT Mid Target
$10.50
SEPT High Target
$13.00
Analyst Consensus
$10.50
Is XRAY a Buy or Sell Right Now?
Thesis
- •Revenue growing -3.0% YoY with DECLINING trend — consistent growth.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment stable.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for XRAY.
Start Free Trial →Is XRAY Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$14.15
19
Moat Score
NONE
6/9
Piotroski Score
0.5
Altman Z-Score
What Is Smart Money Doing with XRAY?
Insider Signal
BUYING
6 buys / 0 sells (90d)
Congress Signal
SELLING
0 buys / 2 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Gladden Brian T | director | Buy | 9,985 | $100K | Jun 15, 2026 |
| MCKEON BRIAN P | director | Buy | 10,000 | $101K | Jun 12, 2026 |
| MAZELSKY JONATHAN JAY | director | Buy | 10,000 | $101K | Jun 12, 2026 |
| HOLDEN BETSY D | director | Buy | 10,086 | $100K | Jun 11, 2026 |
| Barber Michael J | director | Buy | 15,175 | $150K | Jun 11, 2026 |
| LUCIER GREGORY T | director | Buy | 38,382 | - | Jun 3, 2026 |
| LUCIER GREGORY T | director | Sale | 38,382 | - | Jun 3, 2026 |
| Zurbay Donald | director | Buy | 22,822 | - | Jun 3, 2026 |
| Vergis Janet S. | director | Buy | 22,822 | - | Jun 3, 2026 |
| VARON LESLIE F | director | Buy | 22,822 | - | Jun 3, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →XRAY Growth Story
Revenue YoY
-3.0%
3yr Revenue CAGR
-2.1%
EPS Growth YoY
33.04%
FCF Growth YoY
-63.0%
Revenue Trend
DECLINING
Dark Pool Trades for XRAY
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for XRAY, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 19:05:04 | $9.30 | 3,072 | $$29K | SELL |
| 19:03:44 | $9.32 | 4,500 | $$42K | BUY |
| 18:50:39 | $9.35 | 1,709 | $$16K | SELL |
| 18:47:56 | $9.40 | 15,000 | $$141K | BUY |
| 18:39:51 | $9.44 | 3,671 | $$35K | BUY |
5 dark pool trades shown · $$262K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for DENTSPLY SIRONA Inc. (XRAY) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →XRAY — frequently asked questions
What is XRAY stock price today?
DENTSPLY SIRONA Inc. (XRAY) is at $9.30, down 4.66% (-$0.46) at the Nov 12, 2026 close.
Why is XRAY stock moving today?
Latest XRAY news — Nov 9, 2026: Barrington trims DENTSPLY SIRONA target to $11, keeps Outperform rating · Nov 8, 2026: JP Morgan lowers its valuation mark for Dentsply Sirona to $10.00
What is the XRAY price target?
The average analyst price target for XRAY is $10.50, ranging from $10 to $13, based on 8 analysts.
What do analysts rate XRAY?
Analyst ratings for XRAY: 4 Buy, 12 Hold, 1 Sell — consensus Hold.
Did XRAY beat earnings?
XRAY last reported on Nov 5, 2026: EPS $0.29 vs $0.31 expected — a miss of 6.1%.
Does XRAY pay a dividend?
Yes. XRAY's dividend yield is 5.62%.
What are XRAY support and resistance levels?
Support: $9.07, $8.13. Resistance: $9.75, $10.80, $11.71.
What are insiders doing with XRAY?
Insider activity: BUYING, 6 buys and 0 sells in the last 90 days.
What is the latest news on XRAY?
Nov 9, 2026: Barrington trims DENTSPLY SIRONA target to $11, keeps Outperform rating · Nov 8, 2026: JP Morgan lowers its valuation mark for Dentsply Sirona to $10.00 · Nov 7, 2026: BofA Securities sets new $14 target for Dentsply Sirona